| Breakdown | TTM | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 44.96B | 43.79B | 40.21B | 37.73B | 33.92B | 34.05B |
| Gross Profit | 29.43B | 27.49B | 25.49B | 23.21B | 20.48B | 19.92B |
| EBITDA | 3.73B | 3.65B | 2.88B | 1.57B | 358.59M | -3.34B |
| Net Income | 1.15B | 968.52M | 752.04M | -403.19M | 942.53M | -8.75B |
Balance Sheet | ||||||
| Total Assets | 30.47B | 29.20B | 28.73B | 28.73B | 34.12B | 35.79B |
| Cash, Cash Equivalents and Short-Term Investments | 2.78B | 2.26B | 2.29B | 2.37B | 7.91B | 8.35B |
| Total Debt | 8.84B | 8.26B | 8.78B | 9.71B | 14.38B | 17.71B |
| Total Liabilities | 16.53B | 15.56B | 15.87B | 16.86B | 21.60B | 26.17B |
| Stockholders Equity | 13.93B | 13.65B | 12.86B | 11.87B | 12.50B | 9.60B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 889.33M | 971.51M | -539.58M | 892.84M | -5.59B |
| Operating Cash Flow | 0.00 | 3.10B | 2.88B | 1.35B | 2.46B | -3.41B |
| Investing Cash Flow | 0.00 | -2.27B | -1.95B | -2.08B | -1.49B | -846.57M |
| Financing Cash Flow | 0.00 | -919.50M | -1.05B | -4.81B | -1.41B | 10.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥330.40B | 22.28 | 9.66% | 0.55% | 14.33% | 36.83% | |
70 Outperform | ¥132.59B | 20.09 | ― | 0.70% | 5.15% | 47.13% | |
69 Neutral | ¥58.54B | 52.27 | ― | 0.56% | 7.52% | 3.37% | |
63 Neutral | ¥796.71B | 45.71 | 9.53% | 0.55% | 15.58% | 60.90% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥148.60B | 43.18 | ― | 1.71% | 9.51% | 6.29% | |
53 Neutral | ¥215.99B | 72.52 | ― | 0.69% | 10.75% | -14.28% |